What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab… bypharmanewsdailyDecember 2, 2019